These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 21963461

  • 1. Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease.
    Opstad TB, Pettersen AA, Weiss TW, Akra S, Øvstebø R, Arnesen H, Seljeflot I.
    Clin Chim Acta; 2012 Jan 18; 413(1-2):113-20. PubMed ID: 21963461
    [Abstract] [Full Text] [Related]

  • 2. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
    Brunner S, Kim JO, Methe H.
    Am J Cardiol; 2010 Feb 15; 105(4):429-34. PubMed ID: 20152234
    [Abstract] [Full Text] [Related]

  • 3. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms.
    Nanni S, Melandri G, Hanemaaijer R, Cervi V, Tomasi L, Altimari A, Van Lent N, Tricoci P, Bacchi L, Branzi A.
    Transl Res; 2007 Mar 15; 149(3):137-44. PubMed ID: 17320799
    [Abstract] [Full Text] [Related]

  • 4. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease.
    Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G, Meyer J, Cambien F, Tiret L, AtheroGene Investigators.
    Circulation; 2003 Apr 01; 107(12):1579-85. PubMed ID: 12668489
    [Abstract] [Full Text] [Related]

  • 5. Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the outcome of coronary artery disease.
    Jguirim-Souissi I, Jelassi A, Slimani A, Addad F, Hassine M, Hamda KB, Najah M, Maatouk F, Rouis M, Slimane MN.
    Coron Artery Dis; 2011 Apr 01; 22(6):388-93. PubMed ID: 21606841
    [Abstract] [Full Text] [Related]

  • 6. Variation in the human matrix metalloproteinase-9 gene is associated with arterial stiffness in healthy individuals.
    Yasmin, McEniery CM, O'Shaughnessy KM, Harnett P, Arshad A, Wallace S, Maki-Petaja K, McDonnell B, Ashby MJ, Brown J, Cockcroft JR, Wilkinson IB.
    Arterioscler Thromb Vasc Biol; 2006 Aug 01; 26(8):1799-805. PubMed ID: 16709939
    [Abstract] [Full Text] [Related]

  • 7. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
    Rollin J, Régina S, Vourc'h P, Iochmann S, Bléchet C, Reverdiau P, Gruel Y.
    Lung Cancer; 2007 May 01; 56(2):273-80. PubMed ID: 17208328
    [Abstract] [Full Text] [Related]

  • 8. Elevated levels of circulating matrix metalloproteinase-9 are associated with a dysregulated cortisol rhythm--A case-control study of coronary artery disease.
    Szymanowski A, Nijm J, Kristenson M, Jonasson L.
    Psychoneuroendocrinology; 2011 Jan 01; 36(1):139-43. PubMed ID: 20674181
    [Abstract] [Full Text] [Related]

  • 9. Gene polymorphisms and antigen levels of matrix metalloproteinase-1 in type 2 diabetes mellitus coexisting with coronary heart disease.
    Drzewoski J, Sliwińska A, Przybyłowska K, Sliwiński T, Kasznicki J, Zurawska-Klis M, Kosmalski M, Majsterek I.
    Kardiol Pol; 2008 Oct 01; 66(10):1042-8; discussion 1049. PubMed ID: 19006025
    [Abstract] [Full Text] [Related]

  • 10. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
    Przybylowska K, Kluczna A, Zadrozny M, Krawczyk T, Kulig A, Rykala J, Kolacinska A, Morawiec Z, Drzewoski J, Blasiak J.
    Breast Cancer Res Treat; 2006 Jan 01; 95(1):65-72. PubMed ID: 16267613
    [Abstract] [Full Text] [Related]

  • 11. Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease.
    Hlatky MA, Ashley E, Quertermous T, Boothroyd DB, Ridker P, Southwick A, Myers RM, Iribarren C, Fortmann SP, Go AS, Atherosclerotic Disease, Vascular Function and Genetic Epidemiology (ADVANCE) Study.
    Am Heart J; 2007 Dec 01; 154(6):1043-51. PubMed ID: 18035073
    [Abstract] [Full Text] [Related]

  • 12. Genetic polymorphism c.1562C>T of the MMP-9 is associated with macroangiopathy in type 2 diabetes mellitus.
    Wang Y, Su Y, Xu Y, Pan SH, Liu GD.
    Biochem Biophys Res Commun; 2010 Jan 01; 391(1):113-7. PubMed ID: 19909726
    [Abstract] [Full Text] [Related]

  • 13. A close relationship between functional polymorphism in the promoter region of matrix metalloproteinase-9 and acute myocardial infarction.
    Koh YS, Chang K, Kim PJ, Seung KB, Baek SH, Shin WS, Lim SH, Kim JH, Choi KB.
    Int J Cardiol; 2008 Jul 21; 127(3):430-2. PubMed ID: 17698228
    [Abstract] [Full Text] [Related]

  • 14. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.
    Wu TC, Leu HB, Lin WT, Lin CP, Lin SJ, Chen JW.
    Eur J Clin Invest; 2005 Sep 21; 35(9):537-45. PubMed ID: 16128859
    [Abstract] [Full Text] [Related]

  • 15. A functional matrix metalloproteinase (MMP)-9 polymorphism modifies plasma MMP-9 levels in subjects environmentally exposed to mercury.
    Jacob-Ferreira AL, Passos CJ, Gerlach RF, Barbosa F, Tanus-Santos JE.
    Sci Total Environ; 2010 Sep 01; 408(19):4085-92. PubMed ID: 20554312
    [Abstract] [Full Text] [Related]

  • 16. Functional matrix metalloproteinase (MMP)-9 genetic variants modify the effects of hemodialysis on circulating MMP-9 levels.
    Marson BP, Lacchini R, Belo V, Mattos SG, da Costa BP, Poli-de-Figueiredo CE, Tanus-Santos JE.
    Clin Chim Acta; 2012 Dec 24; 414():46-51. PubMed ID: 23010359
    [Abstract] [Full Text] [Related]

  • 17. Analysis of the MMP-9 (C-1562 T) and TIMP-2 (G-418C) gene promoter polymorphisms in patients with chronic periodontitis.
    de Souza AP, Trevilatto PC, Scarel-Caminaga RM, de Brito RB, Barros SP, Line SR.
    J Clin Periodontol; 2005 Feb 24; 32(2):207-11. PubMed ID: 15691353
    [Abstract] [Full Text] [Related]

  • 18. Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.
    Ozkök E, Aydin M, Babalik E, Ozbek Z, Ince N, Kara I.
    Med Sci Monit; 2008 Oct 24; 14(10):CR536-42. PubMed ID: 18830194
    [Abstract] [Full Text] [Related]

  • 19. Role of proinflammatory alleles in longevity and atherosclerosis: results of studies performed on -1562C/T MMP-9 in centenarians and myocardial infarction patients from Sicily.
    Nuzzo D, Vasto S, Balistreri CR, Di-Carlo D, Listì F, Caimi G, Caruso M, Hoffmann E, Incalcaterra E, Lio D, Caruso C, Candore G.
    Ann N Y Acad Sci; 2006 Nov 24; 1089():496-501. PubMed ID: 17261792
    [Abstract] [Full Text] [Related]

  • 20. Plasma metalloproteinase-12 and tissue inhibitor of metalloproteinase-1 levels and presence, severity, and outcome of coronary artery disease.
    Jguirim-Souissi I, Jelassi A, Addad F, Hassine M, Najah M, Ben Hamda K, Maatouk F, Ben Farhat M, Bouslema A, Rouis M, Slimane MN.
    Am J Cardiol; 2007 Jul 01; 100(1):23-7. PubMed ID: 17599435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.